« Back to Record
Citation APA

Kerem, E., Wilschanski, M., Konstan, M. M., Deboeck, K., Accurso, F. F., Sermet-Gaudelus, I., Elborn, S. J., Melotti, P., Bronsveld, I., Fajac, I., Malfroot, A., Rosenbluth, D. D., Walker, P. P., McColley, S. S., Knoop, C., Quattrucci, S., Rietschel, E., Zeitlin, P. P., Barth, J., Elfring, G. G., Welch, E. E., Branstrom, A., Spiegel, R. R., Peltz, S. S., Ajayi, T., & Rowe, S. S. (2014). Ataluren for the treatment of nonsense-mutation cystic fibrosis: A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet Respiratory Medicine, 2(7), 539-547. doi:10.1016/S2213-2600(14)70100-6


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/192420

Kerem, E., Wilschanski, M., Konstan, M. M., Deboeck, K., Accurso, F. F., Sermet-Gaudelus, I., Elborn, S. J., Melotti, P., Bronsveld, I., Fajac, I., Malfroot, A., Rosenbluth, D. D., Walker, P. P., McColley, S. S., Knoop, C., Quattrucci, S., Rietschel, E., Zeitlin, P. P., Barth, J., Elfring, G. G., Welch, E. E., Branstrom, A., Spiegel, R. R., Peltz, S. S., Ajayi, T., & Rowe, S. S. (2014). Ataluren for the treatment of nonsense-mutation cystic fibrosis: A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet Respiratory Medicine, 2(7), 539-547. doi:10.1016/S2213-2600(14)70100-6